BridgeBio Pharma
(NASDAQ) BBIO
BridgeBio Pharma Financials at a Glance
Market Cap
$13.23B
Revenue (TTM)
$579.96M
Net Income (TTM)
-$725.93M
EPS (TTM)
-$3.75
P/E Ratio
-18.03
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$66.88
Volume
1,545,540
Open
$67.67
Price
$66.88
Volume
1,545,540
Open
$67.67
Previous Close
$66.80
Daily Range
$66.79 - $68.20
52-Week Range
$38.57 - $84.94
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$66.88
Volume
1,545,540
Open
$67.67
Previous Close
$66.80
Daily Range
$66.79 - $68.20
52-Week Range
$38.57 - $84.94
Estimated Earnings Date
Aug 4, 2026
BBIO News
BBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BridgeBio Pharma
Industry
Biotechnology
Sector
Health CareEmployees
839
CEO
Neil Kumar, PhD
Website
www.bridgebio.comHeadquarters
Palo Alto, CA 94301, US
BBIO Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
-98%
Net Income Margin
-1%
Return on Equity
0%
Return on Capital
-1%
Return on Assets
-53%
Earnings Yield
-5.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.23B
Shares Outstanding
195.86M
Volume
1.55M
Avg. Volume
2.47M
Financials (TTM)
Gross Profit
$473.81M
Operating Income
-$569.09M
EBITDA
-$672.88M
Operating Cash Flow
-$445.91M
Capital Expenditure
-$1.10M
Free Cash Flow
-$447.01M
Cash & ST Invst.
$587.48M
Total Debt
$2.73B
BridgeBio Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$194.52M
+66.8%
Gross Profit
$184.09M
+61.5%
Gross Margin
94.64%
N/A
Market Cap
$13.23B
N/A
Market Cap/Employee
$18.25M
N/A
Employees
725
N/A
Net Income
-$164.04M
+2.0%
EBITDA
-$112.55M
+10.8%
Quarterly Fundamentals
Total Cash
$940.19M
+73.9%
Total Debt
$3.38B
+82.2%
Accounts Receivable
$205.23M
+78.0%
Inventory
$32.98M
+734.1%
Long Term Debt
$2.81B
+51.7%
Short Term Debt
$573.41M
+10908.1%
Return on Assets
-52.95%
N/A
Return on Invested Capital
-1.03%
N/A
Free Cash Flow
-$197.35M
+1.7%
Operating Cash Flow
-$197.28M
+1.0%